Detection of novel Plasmodium falciparum coronin gene mutations in a recrudescent ACT-treated patient in South-Western Nigeria
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1366563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Olusola Ajibaye und 12 weiteren Autor:innen. Beteiligte Einrichtung: Malaria Genomics Research and Training Centre, Department of Biochemistry & Nutrition, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria. Hauptthemen laut MEDLINE: Antimalarials, Artemisinins, Drug Resistance, Malaria, Falciparum. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS.
Abstract (Originalsprache)
Background
Routine surveillance for antimalarial drug resistance is critical to sustaining the efficacy of artemisinin-based Combination Therapies (ACTs). Plasmodium falciparum kelch-13 (Pfkelch-13) and non- Pfkelch-13 artemisinin ( ART) resistance-associated mutations are uncommon in Africa. We investigated polymorphisms in Plasmodium falciparum actin-binding protein (Pfcoronin ) associated with in vivo reduced sensitivity to ART in Nigeria.
Methods
Fifty-two P. falciparum malaria subjects who met the inclusion criteria were followed up in a 28-day therapeutic efficacy study of artemether-lumefantrine in Lagos, Nigeria. Parasite detection was done by microscopy and molecular diagnostic approaches involving PCR amplification of genes for Pf 18S rRNA, var ATS, telomere-associated repetitive elements-2 (TARE-2). Pfcoronin and Pfkelch-13 genes were sequenced bi-directionally while clonality of infections was determined using 12 neutral P. falciparum microsatellite loci and msp2 analyses. Antimalarial drugs (sulfadoxine-pyrimethamine, amodiaquine, chloroquine and some quinolones) resistance variants (DHFR_51, DHFR_59, DHFR_108, DHFR_164, MDR1_86, MDR1_184, DHPS_581 and DHPS_613) were genotyped by high-resolution melting (HRM) analysis.
Results
A total of 7 (26.92%) cases were identified either as early treatment failure, late parasitological failure or late clinical failure. Of the four post-treatment infections identified as recrudescence by msp2 genotypes, only one was classified as recrudescence by multilocus microsatellites genotyping. Microsatellite analysis revealed no significant difference in the mean allelic diversity, He , (P = 0.19, Mann-Whitney test). Allele sizes and frequency per locus implicated one isolate. Genetic analysis of this isolate identified two new Pfcoronin SNVs (I68G and L173F) in addition to the P76S earlier reported. Linkage-Disequilibrium as a standardized association index, I A S , between multiple P. falciparum loci revealed significant LD ( I A S = 0.2865, P =0.02, Monte-Carlo simulation) around the neutral microsatellite loci. The pfdhfr/pfdhps/pfmdr1 drug resistance-associated haplotypes combinations, (108 T/N /51 I/ 164 L /59 R /581 G /86 Y /184 F ), were observed in two samples.
Conclusion
Pfcoronin mutations identified in this study, with potential to impact parasite clearance, may guide investigations on emerging ART tolerance in Nigeria, and West African endemic countries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Malaria Genomics Research and Training Centre, Department of Biochemistry & Nutrition, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
- Medical Research Council Unit, the Gambia - The London School of Hygiene and Tropical Medicine, Fajara, Banjul, Gambia.
- Center for Molecular Parasitology, Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia, PA, United States.
- Department of Obstetrics and Gynaecology, Lagos University Teaching Hospital, Idi-araba, Surulere, Lagos, Nigeria.
- Department of Biochemistry, Ahmadu Bello University, Zaria, Nigeria.
- Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.
Förderung
- FIC NIH HHS
Zitieren
APA
Ajibaye, O., Olukosi, Y. A., Oriero, E. C., Oboh, M. A., Iwalokun, B., Nwankwo, I. C., Nnam, C. F., Adaramoye, O. V., Chukwemeka, S., Okanazu, J., Gabriel, E., Balogun, E. O., & Amambua-Ngwa, A. (2024). Detection of novel Plasmodium falciparum coronin gene mutations in a recrudescent ACT-treated patient in South-Western Nigeria. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1366563
Vancouver
Ajibaye O, Olukosi YA, Oriero EC, Oboh MA, Iwalokun B, Nwankwo IC, et al. Detection of novel Plasmodium falciparum coronin gene mutations in a recrudescent ACT-treated patient in South-Western Nigeria. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1366563
BibTeX
@article{Ajibaye2024,
author = {Ajibaye, Olusola and Olukosi, Yetunde Adeola and Oriero, Eniyou C and Oboh, Mary Aigbiremo and Iwalokun, Bamidele and Nwankwo, Ikechukwu Chidiebere and Nnam, Chinaza Favour and Adaramoye, Olawunmi Victoria and Chukwemeka, Somadina and Okanazu, Judith and Gabriel, Eniafe and Balogun, Emmanuel Oluwadare and Amambua-Ngwa, Alfred},
title = {Detection of novel Plasmodium falciparum coronin gene mutations in a recrudescent ACT-treated patient in South-Western Nigeria},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1366563}
}
EUVIMED